B

Brown & Brown Insurance

Provides risk management and insurance solutions

Senior Director of Regulatory & Legislative Strategy - Public Sector

Full-TimeUpdated on 10/9/2026
No salary listed
Expert
Bachelor's, Master's, JD
Florida, USA
Remote
ConsultingRisk, Regulatory & Legal Advisory

About the job

Requirements
  • A minimum of 10–15 years of experience in employee benefits compliance, ERISA and non-ERISA governmental plan law, or senior-level benefits consulting.
  • A bachelor's degree in Business Administration, Human Resources, Public Administration, or a related field.
  • At least 3 years of direct experience working with governmental entities such as cities, counties, or school boards.
  • Working knowledge of Florida Chapter 112 provisions concerning public officers and employees.
  • Working knowledge of Sunshine Law and Public Records compliance.
  • Working knowledge of governmental procurement and request-for-proposal cycles.
  • A proven track record of delivering presentations or webinars to large audiences of 100 or more attendees.
  • Experience participating in finalist meetings or oral presentations as a technical subject matter specialist to help win new business.
  • Extensive experience reviewing and redlining Administrative Services Only, Third-Party Administration, and pharmacy benefit manager contracts.
Responsibilities
  • Act as the lead legal and regulatory consultant for public-sector clients regarding employer-sponsored health and welfare plans, including medical, dental, vision, life and accidental death and dismemberment, disability, and retiree coverage.
  • Apply federal mandates to governmental plans, including the Affordable Care Act Section 4980H, Health Insurance Portability and Accountability Act, Consolidated Omnibus Budget Reconciliation Act, Mental Health Parity and Addiction Equity Act, No Surprises Act, RxDC reporting, and Transparency in Coverage.
  • Advise on Florida-specific requirements, including Chapter 112 provisions, Sunshine Law considerations for benefits records, and public board approval processes.
  • Manage the company's group health plan compliance calendar and provide consultant teams with detailed information about compliance-related deadlines, including Gag Clause Prohibition Attestations, RxDC submissions, and Transparency in Coverage updates in coordination with carriers and third-party administrators.
  • Oversee Affordable Care Act Forms 1094/1095-C reporting strategies, variable-hour determinations, and measurement-period policies tailored to governmental workforces.
  • Lead Health Insurance Portability and Accountability Act privacy and security programs, including risk assessments, incident-response coordination, and training for self-funded group health plan sponsors.
  • Build and deliver specialized training for human resources teams, boards, and unions on evolving compliance topics and developments.
  • Develop proprietary templates, checklists, model policies, and decision memoranda, such as Health Savings Account and Health Reimbursement Arrangement compliance or retiree coverage strategy.
  • Monitor federal and state legislative, regulatory, and judicial developments to publish actionable client alerts with practical implementation timelines.
  • Review, mark up, negotiate, and finalize legal-risk and commercial provisions within client services agreements, Health Insurance Portability and Accountability Act Business Associate Agreements, Third-Party Administration and Administrative Services Only contracts, vendor and consultant agreements, and stop-loss carrier agreements and policies, in collaboration with the legal team as appropriate.
Desired Qualifications
  • A Juris Doctor or Master of Laws degree.

About the company

B

Brown & Brown Insurance

View

Brown & Brown provides risk management and insurance solutions to businesses and individuals through its Retail and Specialty Distribution segments. The company works by acting as an intermediary to identify specific risks and connect customers with tailored insurance policies that protect their assets. Unlike many competitors, it combines the scale of a large global brokerage with a decentralized culture that emphasizes local community involvement and a team-based approach to service. Its goal is to provide superior risk protection and long-term security for customers by consistently prioritizing their best interests.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Leeds, United Kingdom

Founded

1914

Get referred to Brown & Brown Insurance

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 30.4%; adjusted EBITDA hit $598 million.
  • Management expects $30 million-$40 million in Accession synergies during 2026.
  • Second-half organic growth guidance stays positive: Retail 1.5%-2.5%, Specialty Distribution 2%-4%.

What critics are saying

  • Organic revenue fell 0.7% in Q2 2026, exposing acquisition dependence.
  • Interest expense doubled to $100 million after Accession debt, squeezing margins and buybacks.
  • Private-equity-backed brokers keep poaching producers; one bad retention cycle can break organic growth.

What makes Brown & Brown Insurance unique

  • Accession added 2026 scale, lifting second-quarter revenue 30.4% to $1.68 billion.
  • Anthropic, McKinsey, and Accenture embed AI across 23,000 employees, widening operating leverage.
  • Brown & Brown spans 44 states and 14 countries, reducing dependence on any one market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Student Loan Assistance

Tuition Reimbursement

Mental Health Support

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Oct 12th, 2026
Brown & Brown's core growth stalls as insurer payments mask a 0.3% organic revenue decline

Brown & Brown (NYSE: BRO), an insurance broker, faces pressure as falling catastrophe-property rates cut commissions. First-half 2026 organic revenue fell 0.3%, though it rose 1.6% when contingent commissions from insurers are included. Contingent commissions, which depend largely on insurers' underwriting profits, have cushioned the decline. The company's Specialty Distribution division shrank 3.5% in the second quarter, while Retail grew 1.5%. The August 2025 acquisition of RSC Topco, Inc. lifted reported revenue 30.4%. Quarterly interest expense rose to $100 million from $51 million, and diluted shares increased to 334 million from 293 million. The stock trades at about 13x forward earnings, against 20x trailing. Rival Arthur J. Gallagher & Co. trades at about 16x, with faster expected earnings growth.

Yahoo Finance
Aug 14th, 2026
Brown & Brown stock trades at 15.04X P/E, below industry average of 16.51X

Brown & Brown shares are trading at a discount to the insurance brokerage industry, with a forward price-to-earnings ratio of 15.04X versus the industry average of 16.51X. The company has a market capitalisation of $23.96 billion. The stock has gained 27.4% over the past three months, outperforming the industry's 22.4% growth. Analysts' average price target of $76.44 suggests a potential 7.6% upside from recent levels. The Zacks Consensus Estimate projects 2026 earnings per share to increase 5.6% year-over-year, with revenues reaching $7.04 billion, up 19.2%. Growth is supported by increasing new business, strong client retention, and strategic acquisitions. The company's recent Accession acquisition contributed approximately $410 million to second-quarter 2026 revenues, with expected synergies of $30-$40 million in 2026.

Yahoo Finance
Aug 13th, 2026
Brown & Brown tops insurance brokers' revenue growth but misses Q2 estimates by 2.5%

Five insurance brokers stocks reported largely satisfactory Q2 earnings, with revenues beating analyst consensus estimates by 0.8% overall. Share prices have held steady, rising 2.1% on average since results were released. Brown & Brown reported revenues of $1.68 billion, up 30.4% year on year. However, this figure fell short of analyst expectations by 2.5%. Despite scoring the fastest revenue growth amongst peers, it had the weakest performance against analyst estimates. The stock has risen 2.7% since reporting and currently trades at $71.60. Ryan Specialty delivered the strongest Q2 performance, reporting revenues of $916.6 million, up 7.2% year on year and outperforming analyst expectations by 5.3%. The insurance brokerage industry benefits from rising risk complexity and regulatory scrutiny, though faces challenges from labour intensity and wage inflation.

Yahoo Finance
Aug 3rd, 2026
Brown & Brown Q2 revenue misses estimates at $1.68B despite 30% growth

Brown & Brown reported second quarter 2026 results that missed revenue expectations but showed strong year-on-year growth. Revenue rose 30.4% to $1.68 billion, below the $1.72 billion analyst estimate. Management attributed performance to strong contingent commissions, effective acquisition integration, and improved sales processes. CEO J. Powell Brown said the company's enhanced sales model is building momentum with aligned teams generating new business wins. Operating margin declined year-over-year to 22.9% from 24.2%, though the company made progress controlling expenses. Adjusted EBITDA of $611 million beat analyst estimates of $603.1 million. During the earnings call, analysts questioned MGA competition impacts, European expansion plans, and technology investment costs. Management stressed disciplined underwriting and confirmed synergy targets remain unchanged.

Yahoo Finance
Aug 1st, 2026
Brown & Brown reports Q2 revenue of $1.68B but trades 6.9% below fair value target of $75.63

Brown & Brown reported Q2 2026 results with revenue of $1.676 billion and net income of $288 million. The insurance broker's shares closed at $70.40, posting a 22.16% gain over 90 days but down 9.30% year-to-date and 23.00% over one year. Valuation models suggest a fair value of $75.63, indicating the stock is 6.9% undervalued. The company's diversified portfolio across geographies and business lines supports earnings stability. However, the price-to-earnings ratio of 19.8x exceeds both the US insurance industry average of 12.1x and the stock's fair ratio of 12.5x. Risks include rising pharmacy costs in benefits and potential Florida legislative changes that could pressure margins.